Amid mass pharmacies closures, San Francisco explores co-op modelSan Francisco seeks to support mom-and-pop pharmacies amid a wave of closures, exploring co-op models for purchasing and insurance reimbursements.
Independent pharmacies know their communities. But many are struggling to stay openIndependent pharmacies are vital for community health, especially among low-income and elderly populations, yet they are closing at an alarming rate.
Amid mass pharmacies closures, San Francisco explores co-op modelSan Francisco seeks to support mom-and-pop pharmacies amid a wave of closures, exploring co-op models for purchasing and insurance reimbursements.
Independent pharmacies know their communities. But many are struggling to stay openIndependent pharmacies are vital for community health, especially among low-income and elderly populations, yet they are closing at an alarming rate.
Independent drugstore closures threaten to turn communities into "pharmacy deserts"Independent drugstores like Kempson Rexall are vital to rural communities but face significant challenges, leading to a crisis in access to healthcare.
Pharmacy Benefit Managers Aren't Always Good for PharmaciesPharmacy deserts are emerging in the U.S. as independent pharmacies close due to the practices of pharmacy benefit managers.
Letters: Restrain PBMsCongress must act to regulate pharmacy benefit managers (PBMs) to protect patient access to medications and support independent pharmacies.
Independent drugstore closures threaten to turn communities into "pharmacy deserts"Independent drugstores like Kempson Rexall are vital to rural communities but face significant challenges, leading to a crisis in access to healthcare.
Pharmacy Benefit Managers Aren't Always Good for PharmaciesPharmacy deserts are emerging in the U.S. as independent pharmacies close due to the practices of pharmacy benefit managers.
Letters: Restrain PBMsCongress must act to regulate pharmacy benefit managers (PBMs) to protect patient access to medications and support independent pharmacies.
The FTC Released a Scathing Interim Report on PBMs. What's Next? - MedCity NewsThe FTC's investigation on PBMs reveals market concentration and profit generation issues, impacting drug costs and independent pharmacies negatively.